Archives: 2026-04-24

FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program

Groundbreaking AAV-based gene therapy offers potential treatment for patients with OTOF gene-associated severe-to-profound and profound hearing loss The U.S. Food and Drug Administration approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni is indicated for the treatment of pediatric and adult patients with severe-to-profound and profound sensorineural hearing loss (any

Read More


CAR-T cells trials efficacy presented at the America Association for Cancer Research annual meeting

The third Clinical Trials Plenary Session at the AACR Annual Meeting 2026 was dedicated to “Cellular Therapies and Complex Immunotherapies” and provided updates on sophisticated immunotherapeutic CAR-T cells strategies, with special emphasis on their application for solid tumors.  Can CAR T-cell therapy intercept disease in patients with smoldering myeloma? The first presenter Omar Nadeem, MD, of

Read More


Redo Surgical Mitral Valve Replacement Shows Long-Term Survival Advantage Over Transcatheter Valve-in-Valve

 A new multicenter study published in The Annals of Thoracic Surgery finds that reoperative surgical mitral valve replacement (rSMVR) is associated with significantly better long-term survival compared to transcatheter mitral valve-in-valve (mViV) procedures in patients with failing bioprosthetic mitral valves. While both approaches demonstrated similar safety and procedural success at 30 days, key differences emerged over time,

Read More


Research published in JAMA: Mortality Among ICE Detainees Surging in 2026

Over a 22-year period, 272 deaths were reported; nearly half cited “undetermined” causes Key Takeaways Deaths among people detained by Immigration and Customs Enforcement (ICE) have increased in recent years after a long decline, and better monitoring of medical care and mortality rates in this population is needed, said researchers of a retrospective study. From

Read More


Millions of Americans Now Consult AI Before, After, and Sometimes Instead of, Seeing a Doctor

Over half of recent AI users say they research health questions before or after seeing a doctor, though most still prefer a provider for sensitive conversations. Story Highlights As artificial intelligence becomes increasingly embedded in daily life, the West Health-Gallup Center on Healthcare in America reports that 25% of Americans have used an AI tool

Read More


Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects

A Stanford Medicine study taps artificial intelligence to find a naturally occurring molecule called a peptide that suppressed appetite and led to weight loss in mice and pigs. Anaturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide — also known as Ozempic — in suppressing appetite and reducing body weight. Notably, testing

Read More